PacBio names COO Mark Van Oene CEO, replacing Christian Henry

Reuters2026/08/05 20:54

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pacific Biosciences appointed Chief Operating Officer Mark Van Oene as president and CEO, effective Aug. 5, 2026.
Van Oene succeeds Christian Henry, who stepped down as president and CEO after six years.
Van Oene joined PacBio in 2021 as COO, leading operational execution, commercial strategy, product roadmap, clinical development, and AI-related improvements.
Van Oene was appointed to the board, effective Aug. 5, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608051608PRIMZONEFULLFEED9804333) on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

PacBio names COO Mark Van Oene CEO, replacing Christian Henry

You may also like

Crypto prices